The impact of biomaterials on pharmaceutical sciences
- 30 September 1994
- journal article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 2 (1-2) , 7-9
- https://doi.org/10.1016/0928-0987(94)90050-7
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly (ethylene oxide-aspartate) block copolymer-adriamycin conjugatesJournal of Controlled Release, 1994
- Heparin-containing block copolymersJournal of Materials Science: Materials in Medicine, 1993
- Degradable polyphosphazenes for biomedical applicationsJournal of Controlled Release, 1993
- Controlled release of dopamine, insulin and other agents from microencapsulated cellsJournal of Controlled Release, 1993
- Macromolecular engineering of polylactones and polylactides. 5. Synthesis and characterization of diblock copolymers based on poly-iε-caprolactone and poly(L,L or D,L)lactide by aluminum alkoxidesMacromolecules, 1991
- Development of poly(ortho esters): a historical overviewBiomaterials, 1990
- The potential of water-soluble polymeric carriers in targeted and site-specific drug deliveryJournal of Controlled Release, 1990
- Polyanhydrides. I. Preparation of high molecular weight polyanhydridesJournal of Polymer Science Part A: Polymer Chemistry, 1987
- Polymers for biodegradable medical devices. 1. The potential of polyesters as controlled macromolecular release systemsJournal of Controlled Release, 1986
- The synthesis and characterization of polypeptide-adriamycin conjugates and its complexes with adriamycin. Part IJournal of Controlled Release, 1985